Experience: Kristin’s practice includes the clearance, enforcement and exploitation of brand names, proceedings before the Trademark Trial and Appeal Board, domain name dispute resolution, intellectual property mediation, licensing matters including trademark, copyright and brand management, and litigation support for intellectual property and entertainment-related claims. Kristin is also involved in the intellectual property and commercial aspects of various corporate transactions and assists a variety of start-up companies in creative fields. In addition to her extensive work regarding trademarks and domain names, Kristin has experience preparing and prosecuting patent applications in various types of subject matter, including wearable devices, innovative mechanical apparatus, beauty products, cosmetics, hair preparations, nutritional items, and biotechnology.
Kristin advises domestic and international clients in various industries such as fitness, fashion, restaurant services, luxury goods, vitamin and nutritional supplements, cosmetics, toys, new media, computer games, software, and industrial products.
Kristin is a member of the International Trademark Association (INTA) Alternative Dispute Resolution Committee and is a panel member of the INTA Trademark Mediator’s Network. Also, she is on the panel of neutrals of FORUM, an alternative dispute resolution organization.
Seton Hall University School of Law, J.D., 2001
Drew University, B.A., magna cum laude, Biology, 1997
Stanford University, 1993-4
“Fashion and Apparel Licensing,” Chapter in Fashion Law: A Guide for Designers, Fashion Executives, and Attorneys, pp. 81-104 (2009) (Barbara Kolsun, Kristin B. Kosinski)
“Hatch-Waxman in the Federal Courts: 1994-2004,” Drug Development and Industrial Pharmacy, 31(2): 15-22 (2005) (S. Peter Ludwig, Kristin B. Kosinski)
“Generic Drug Approval: Post 1984; Hatch-Waxman Reform,” Chapter in Introduction to the Pharmaceutical Regulatory Process, I. Berry, Editor (2005) (S. Peter Ludwig, Marc Gross, Atul Singh, Kristin B. Kosinski)
“Patents and Polymorphs” Chapter in Biotechnology and Pharmaceutical Law 2004: Patents and Business Strategies, Practicing Law Institute Intellectual Property Course Handbook Series (S. Peter Ludwig, Kristin B. Kosinski)
“Playing by the Orange Book Listing Rules in View of Recent Hatch-Waxman Reforms,” Food Drug L. Reg. and Educ. 10 (2004)
“Research Tool Patents and the Section 271(e)(1) Exemption,” Chapter in Biotechnology Law 2003: Biotechnology Patents & Business Strategies, Practicing Law Institute Intellectual Property Course Handbook Series (Robert C. Sullivan, Kristin B. Kosinski)
Discovering Drugs in Patent File Histories, Food Drug L. Reg. and Educ. 12 (2003)
The Hatch-Waxman Act: Balancing Competing Interests or Survival of the Fittest? 52 Food Drug L. J. 247 (2002)
Cancellation of the Washington Redskins’ Federal Trademark Registrations: Should Sports Team Names, Mascots, and Logos Contain Native American Symbolism? 10 Seton Hall J. Sports L. 289 (2000)
U.S. Patent and Trademark Office
U.S. Court of Appeals for the Ninth Circuit
U.S. District Court for the Central District of California
U.S. District Court for the Southern District of California
New York Bar
New Jersey Bar
Contact: [email protected]